Proxy Statement

MADRIGAL PHARMACEUTICALS, INC. Filed 2022-05-02 Acc 0001193125-22-136035

Documents 1

2023-05-01 DEF 14A Proxy Statement
2022-05-09 10-Q Quarterly Report
2022-05-09 8-K Material agreement · New debt or obligation · Unregistered share sale
2022-05-09 8-K Results of operations
2022-05-02 DEFA14A Proxy Materials
2022-05-02 DEF 14A Proxy Statement
2021-04-30 DEF 14A Proxy Statement

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading d289121ddef14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…